In addition, inflammatory responses and blood–brain barrier disruption were associated with poor stroke outcomes [20, 21], and this association was also very evident in patients who experienced hemorrhagic transformation after recombinant tissue plasminogen activator thrombolysis [22]. This evidence concerns the gene PLAT and Stroke.